Zevia lands $20 million growth equity deal and lifts Q3 sales outlook
Zevia PBC agreed to a $20 million convertible preferred stock investment from GP Investments and now expects third-quarter net sales above its prior guidance.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Zevia PBC, the maker of zero-sugar beverages, said it signed a definitive agreement with a fund managed by GP Investments Ltd. to issue convertible preferred stock worth $20 million. The company said the funds will support key strategic priorities and strengthen its balance sheet and financial flexibility. Piper Sandler advised Zevia on evaluating strategic and financing options.
Zevia also said it now expects third-quarter 2026 net sales of about $48 million, above its previous guidance of $44 million to $46 million. Adjusted EBITDA is expected between negative $900 thousand and negative $1.0 million, better than the prior range of negative $3.0 million to negative $3.5 million. The company plans to report third-quarter results on November 4, 2026, after the market close.
why it matters
The deal is modest in size, but it eases near-term funding pressure and the improved quarterly outlook may help sentiment around the stock. Investors will likely focus on the conversion terms and the 6% payment-in-kind dividend.
market impact
Zevia shares: new capital and a stronger sales outlook may support the stock.
tags
instruments
sources
- Zevia Announces $20 Million Growth Equity Investment — TradingView, 22 October 2026 at 21:21 UTC
- Zevia Announces $20 Million Growth Equity Investment — Reuters, 22 October 2026 at 22:23 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗